Needham Comments on CONMED (CNMD) Amid Sale Rumors

July 14, 2026 5:44 AM

Needham analyst Mike Matson reiterated a Hold rating on CONMED (NYSE: CNMD).The analyst comments "After the market closed on 7/10/26 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found